Progress in Neuro-Psychopharmacology and Biological Psychiatry

Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients
pp. 723-739(17)
Authors: Chang W.-H.; Lin S.-K.; Lane H.-Y.; Wei F.-C.; Hu W.-H.; Lam Y.F.; Jann M.W.

Extrapyramidal adverse effects associated with sertraline
pp. 741-748(8)
Authors: Lambert M.T.; Trutia C.; Petty F.

Severe antecollis during antipsychotics treatment: a report of three cases
pp. 749-759(11)
Authors: Maeda K.; Ohsaki T.; Kuki K.; Kin K.; Ikeda M.; Matsumoto Y.

Amphetamine infusions into the prefrontal cortex attenuate the sensitization to amphetamine
pp. 763-773(11)
Authors: Ben-Shahar O.; Ettenberg A.

ICV administration of CRF blocker (CRF_{9-41 &unknown;} helical) reduces morphine withdrawal in rats
pp. 775-785(11)
Authors: Brugger S.; Sanchez R.; Brugger A.J.; Martinez J.A.

Effect of chronic antidepressant treatment on transcription factor binding activity in rat hippocampus and frontal cortex
pp. 787-802(16)
Authors: Frechilla D.; Otano A.; Del Rio J.

Effects of mesulergine treatment on diet selection, brain serotonin (5-HT) and dopamine (DA) turnover in free feeding rats
pp. 803-813(11)
Authors: Giannakopoulos G.; Galanopoulou P.; Daifotis Z.; Couvaris C.

Modulation of central serotonergic neurotransmission by risperidone: underlying mechanism(s) and significance of action
pp. 815-834(20)
Authors: Hertel P.; Lindblom N.; Nomikos G.G.; Svensson T.H.

Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration
pp. 835-844(10)
Authors: Navarro J.F.; Pedraza C.; Martin M.; Manzaneque J.M.; Davila G.; Maldonado E.

Bupropion and desipramine increase dopamine transporter mRNA expression in the ventral tegmental area/substantia nigra of rat brain
pp. 845-856(12)
Authors: Petrie E.C.; Veith R.C.; Szot P.

The antisense strategy applied to the study of dopamine D₃ receptor functions in rat forebrain
pp. 857-882(26)
Authors: Tremblay M.; Rouillard C.; Levesque D.

Neuroethological assessment of amphetamine-induced behavioral changes and their reversal by neuroleptics: focus on the amygdala and nucleus accumbens
pp. 883-905(23)
Authors: Zhongrui W.; Rebec G.V.

Decreased plasma cortisol level during alprazolam treatment of panic disorder: a case report
pp. 909-915(7)
Authors: Fukuda M.; Takazawa S.; Nakagome K.; Iwanami A.; Hata A.; Kasai K.; Hiramatsu K.-I.